文献速递间质性肺疾病肺栓塞与肺血管病

系统性硬化症相关间质性肺病伴与不伴肺动脉高压对生存的影响:德国系统性硬化症网络大型队列研究

Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival: A Large Cohort Study of the German Network for Systemic Sclerosis.
PubMed 文献 · Chest · 2023-08-13

该研究基于德国系统性硬化症网络 registry 的 3257 例患者数据,中位随访 3.45 年,分析 ILD 伴或不伴 PH 的患病率、临床特征及生存。结果显示 ILD 是最常见肺部受累(随访末 47.6%),ILD-PH 生存最差,5 年总生存无肺部受累者为 96.4%,ILD 不伴 PH、PAH 和 ILD-PH 间差异显著且 ILD-PH 最差。

要点

  • SSc 随访末 ILD 患病率 47.6%,ILD-PH 为 15.2%,PAH 为 6.5%。
  • 无肺部受累者 5 年总生存 96.4%,ILD-PH 生存最差。
  • 女性、较高 BMI 和较高 DLCO 与较低死亡风险相关。

核心结论

  • ILD 是 SSc 最常见的肺部受累,ILD 合并 PH 与最差的生存相关。

研究设计与样本

  • 基于德国系统性硬化症网络 registry 的队列研究,纳入 3257 例 SSc 患者,平均随访 3.45±1.63 年。

主要发现

  • 基线时 ILD 患病率 34.5%,无 ILD 的 PH 患病率 4.5%。
  • 随访末 ILD 患病率 47.6%,ILD-PH 为 15.2%,PAH 为 6.5%。
  • 弥漫皮肤型 SSc 中 ILD 更常见(57.3%),PAH 在 SSc 亚型间无显著差异。
  • 无肺部受累者 5 年总生存 96.4%,ILD 不伴 PH、PAH 和 ILD-PH 间生存差异显著,ILD-PH 最差。
  • 女性(HR 0.3)、较高 BMI(HR 0.9)和较高 DLCO(HR 0.98)与较低死亡风险相关。

关键数值与推荐

  • 基线 ILD 患病率 34.5%,无 ILD 的 PH 患病率 4.5%。
  • 随访末 ILD 患病率 47.6%,ILD-PH 为 15.2%,PAH 为 6.5%。
  • 弥漫皮肤型 SSc 中 ILD 频率 57.3%。
  • 无肺部受累者 5 年总生存 96.4%。
  • 女性 HR 0.3,较高 BMI HR 0.9,较高 DLCO HR 0.98,均与较低死亡风险相关。

临床怎么用

  • 对 SSc 患者应评估 ILD 和 PH 的存在,ILD-PH 提示预后更差。
  • 女性、较高 BMI 和较高 DLCO 与较低死亡风险相关,可辅助风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pulmonary involvement is the leading cause of death in systemic sclerosis (SSc) and may manifest as interstitial lung disease (ILD), pulmonary arterial hypertension (PAH), or in combination of both (ILD with pulmonary hypertension [ILD-PH]). The aim of this analysis was to determine prevalence, clinical characteristics, and survival of these different forms within the registry of the German Network for Systemic Sclerosis. RESEARCH QUESTION: Does SSc-associated ILD-PH or ILD without PH affect survival differently, and are there any risk factors that have an additional impact? STUDY DESIGN AND METHODS: Clinical data of 5,831 patients with SSc were collected in the German Network for Systemic Sclerosis registry. Kaplan-Meier estimates were used to compare overall survival in patients with SSc-associated ILD-PH and ILD without PH with patients without pulmonary involvement and those with PAH. The Cox proportional hazard model was used to analyze the influence of pulmonary involvement and other potential predictors on patient survival. RESULTS: Clinical data of 3,257 patients with a mean follow-up time of 3.45 ± 1.63 years have been included in our analysis. At baseline, ILD was present in 34.5%, whereas PH without ILD had a lower prevalence with 4.5%. At the end of follow-up, 47.6% of patients with SSc had ILD, 15.2% had ILD-PH, and 6.5% had PAH. ILD was more frequent in the diffuse cutaneous form (57.3%), whereas PAH did not differ significantly between SSc subtypes. Significant differences in baseline characteristics between PAH vs ILD-PH vs ILD without PH were found for age at diagnosis, sex, SSc subsets, antibody status, FVC, diffusing capacity of the lung for carbon monoxide, and therapy. Overall survival at 5 years was 96.4% for patients without pulmonary involvement and differed significantly between patients with ILD without PH, PAH, and being worst in patients with ILD-PH. Female sex (hazard ratio [HR], 0.3), higher BMI (HR, 0.9), and higher diffusing capacity of the lung for carbon monoxide values (HR, 0.98) were associated with a lower mortality risk. INTERPRETATION: ILD is the most prevalent pulmonary involvement in SSc, whereas the combination of ILD and PH is associated with the most detrimental survival.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Moinzadeh P, Bonella F, Oberste M, et al. Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival: A Large Cohort Study of the German Network for Systemic Sclerosis. Chest. 2023. PMID: 37582424. doi:10.1016/j.chest.2023.08.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。